Check out our most popular compounded medications! Get Started
The Ramelteon 8 mg/5 mL Oral Liquid is a specially crafted medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or tablets, such as those in pediatric and geriatric groups. Ramelteon, the active ingredient, is primarily used in the treatment of insomnia characterized by difficulty with sleep onset. By providing Ramelteon in a liquid form, it ensures that patients who are unable to take solid dosage forms can still receive their necessary treatment for sleep disorders.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ramelteon 8 mg/5 mL Oral Liquid is a custom-prepared medication designed to facilitate ease of administration for patients who may have difficulty swallowing tablets or capsules, such as those in pediatric or geriatric populations. This oral liquid formulation ensures that patients receive the precise dose of ramelteon, which is critical for maintaining its efficacy and safety profile. Ramelteon is a melatonin receptor agonist that is specifically indicated for the treatment of insomnia characterized by difficulty with sleep onset. By mimicking the action of melatonin, a natural hormone that regulates the sleep-wake cycle, ramelteon aids in the initiation of sleep, helping patients fall asleep more quickly.
The 8 mg/5 mL concentration allows for flexible dosing, which can be particularly beneficial for patients who require dosage adjustments or for those with specific needs that cannot be met with standard dosage forms. The liquid formulation is also advantageous for patients with dysphagia or other conditions that impair swallowing. Ramelteon's mechanism of action does not involve the benzodiazepine receptors and is therefore not associated with some of the adverse effects common to other sedative-hypnotic drugs, such as dependence or withdrawal symptoms. This makes ramelteon a suitable option for long-term management of insomnia in various patient populations.
For prescribers, it is important to note that ramelteon should be taken 30 minutes before bedtime and should not be used by patients with severe liver impairment. Additionally, it should not be taken with or immediately after a high-fat meal, as this can affect the drug's absorption. As with all medications, the potential for drug interactions should be considered, and a thorough patient history should be reviewed to ensure the safe use of ramelteon. Monitoring for efficacy and any adverse effects is recommended, especially when initiating therapy or changing doses.
Patients should be counseled on the proper administration of the oral liquid, the importance of adhering to prescribed dosing schedules, and the need to establish good sleep hygiene practices for optimal treatment outcomes. They should also be informed about potential side effects, such as dizziness or somnolence, and advised to avoid engaging in activities that require full alertness after taking ramelteon. As with any medication, patients should be encouraged to report any unusual symptoms or concerns to their healthcare provider promptly.
If you have any questions or require further information about the Ramelteon 8 mg/5 mL Oral Liquid formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to both patients and prescribers to ensure the safe and appropriate use of this medication.
Ramelteon is a sedative, also called a hypnotic, which works by affecting certain substances in your body that help regulate your "sleep-wake cycle." Its primary use is for the treatment of insomnia, specifically in helping patients fall asleep faster. When considering the use of ramelteon 8 mg/5 mL oral liquid, it is important to be aware of potential drug interactions that could affect the safety and efficacy of the medication.
Firstly, ramelteon should be used with caution in combination with fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), as fluvoxamine can significantly increase the concentration of ramelteon in the blood, potentially leading to increased effects or side effects. Patients taking fluvoxamine may require a lower dose of ramelteon to avoid excessive sedation or other adverse effects.
Concomitant use of ramelteon with other central nervous system (CNS) depressants, such as benzodiazepines, opioids, tricyclic antidepressants, antihistamines, or alcohol, may result in additive sedative effects. This could lead to increased drowsiness, dizziness, and further impairment of cognitive and motor performance. Patients should be advised to avoid or limit the use of alcohol while being treated with ramelteon and to be cautious when taking other CNS depressants.
Ramelteon is metabolized by the liver enzyme CYP1A2. Drugs that are strong inhibitors of this enzyme, such as ciprofloxacin or enoxacin, can increase the levels of ramelteon in the body, potentially leading to an increase in its effects and side effects. Conversely, medications that induce CYP1A2, such as omeprazole or rifampin, may decrease the plasma concentration of ramelteon, potentially reducing its efficacy.
Patients should also be aware that smoking can decrease the effectiveness of ramelteon due to the induction of CYP1A2 by polycyclic aromatic hydrocarbons in tobacco smoke. Smokers may require a higher dose of ramelteon for the same effect as non-smokers.
It is important to note that hormonal contraceptives can increase the exposure to ramelteon, which may necessitate a dosage adjustment. Additionally, patients with severe liver impairment should not use ramelteon, as it is extensively metabolized in the liver and could lead to increased levels of the drug in the body.
Given the potential for drug interactions, it is crucial for patients and prescribers to review all medications, including over-the-counter drugs and herbal supplements, that the patient is currently taking before starting ramelteon. Adjustments to therapy or additional monitoring may be necessary to ensure safe and appropriate use of ramelteon oral liquid.
If you have any questions or require further information regarding the use of ramelteon 8 mg/5 mL oral liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the best possible outcomes for our patients.
Ramelteon is a sedative-hypnotic medication that is specifically designed to treat insomnia characterized by difficulty with sleep onset. The active ingredient in this formulation, ramelteon, works by mimicking the activity of melatonin, a natural hormone produced by the body that helps regulate the sleep-wake cycle. Ramelteon binds selectively to melatonin receptors in the brain, particularly MT1 and MT2 receptors, which are involved in the control of circadian rhythms and the promotion of sleepiness. By activating these receptors, ramelteon helps to facilitate the onset of sleep without significantly altering the architecture of sleep, which is a common issue with other types of sleep aids.
The 8 mg/5 mL oral liquid formulation of ramelteon provides a precise dosage that can be easily measured and administered, making it particularly suitable for patients who have difficulty swallowing pills, such as the elderly or children, as well as those with neurodegenerative disorders or dysphagia. The liquid form allows for flexible dosing and can be a more palatable option for patients who are averse to the taste or texture of tablets or capsules. Additionally, the liquid formulation ensures that the medication is absorbed quickly into the bloodstream, allowing for a faster onset of action compared to solid dosage forms.
When using this formulation, it is important for both patients and prescribers to understand that ramelteon should be taken 30 minutes before bedtime and should not be taken with or immediately after a high-fat meal, as this can affect the absorption of the medication. It is also crucial to maintain a consistent sleep schedule and to use ramelteon only as directed by a healthcare professional. As with any medication, there may be potential side effects, and it is important to discuss these with a healthcare provider before starting treatment with ramelteon.
For those interested in using this ramelteon 8 mg/5 mL oral liquid formulation, or for more detailed information about the medication and its use in treating insomnia, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is available to answer any questions and provide guidance on the appropriate use of this medication to ensure appropriate treatment of sleep disorders.
Ramelteon 8 mg/5 mL Oral Liquid is a medication used to treat sleep onset insomnia. It helps patients who have difficulty falling asleep to achieve faster sleep onset by mimicking the effects of the naturally occurring hormone melatonin in the body.
The medication should be taken exactly as prescribed by your healthcare provider. It is usually taken once daily, 30 minutes before bedtime. The liquid formulation should be measured with the provided dosing syringe or cup to ensure the correct dose is administered.
Ramelteon oral liquid can be prescribed to both adults and selected pediatric patients who have trouble swallowing pills, as well as geriatric patients who may have difficulties with solid dosage forms.
It is recommended to take Ramelteon on an empty stomach for better absorption. Taking it with food can delay the onset of action of the medication and reduce its effectiveness.
Yes, as with all medications, Ramelteon can cause side effects. Common side effects include dizziness, tiredness, and headaches. Severe side effects are rare but can include allergic reactions, sleepwalking, and abnormal thoughts or behavior. Notify your healthcare provider if you experience any side effects.
Ramelteon is generally prescribed for short-term treatment of insomnia. Its safety and effectiveness for long-term use have not been established. Discuss with your healthcare provider if you need long-term treatment options.
The medication should be stored at room temperature, away from light and moisture. Keep it out of reach of children and pets, and do not use it beyond its expiration date.
Ramelteon is not considered habit-forming, and it is unlikely to cause dependence or withdrawal symptoms. However, it is still important to use it as directed by your healthcare provider.
If you miss a dose, skip it and take your next dose at the usual time. Do not take a double dose to make up for the missed one, as taking more than the recommended dose can increase the risk of side effects.
The safety of Ramelteon in pregnant or breastfeeding women has not been adequately studied. If you are pregnant or breastfeeding, you should only use this medication if it is clearly needed. Discuss all potential risks and benefits with your healthcare provider.
While taking this medication, you should avoid alcohol and refrain from driving or operating heavy machinery until you know how Ramelteon affects you. Alcohol can increase the sedative effects and worsen other side effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
